Episode Details

Back to Episodes

Ep. 129: Live from IMMUNOLOGY2026TM: Emerging Immunotherapies for Solid Tumors

Published 2 months, 3 weeks ago
Description

Guest:

This special episode was recorded in front of a live audience at IMMUNOLOGY2026™ in Boston. Brenda and Jason sit down with Dr. Charles Sentman, Director of the Center for Synthetic Immunity at Dartmouth College, and Dr. Giulia Escobar, Director of Pre-Clinical Research at Massachusetts General Hospital, to explore new strategies aimed at overcoming the unique challenges of treating solid tumors. They focus on real-world challenges in CAR T and NK cell therapies, including barriers to treating solid tumors, manufacturing and accessibility hurdles, and emerging applications beyond oncology, such as autoimmunity and neurodegenerative disease.

Featured Products and Resources:

Image courtesy of [Drs. Charles Sentman and Giulia Escobar]

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us